Abstract:AIM:To construct recombinant eukaryotic expression vectors pEGFP-C3-SNCA containing human wild-type (WT) and pathogenic mutations A30P, A53T alpha-synuclein (SNCA), and to obtain monoclonal PC12 cell lines overexpressing human wild-type and pathogenic mutations A30P, A53T alpha-synuclein by stable transfection.METHODS:Human wild type SNCA gene was cloned by using RT-PCR. By T-A extension cloning, the gene was ligated with T-vector and sequenced. Based on it, the recombinant eukaryotic expression vectors containing wild type SNCA synonymous mutation or its G88C (Ala30Pro) and G209A (Ala53Thr) pathogenic mutation were constructed by site-directed mutagensis using primer variance in mononucleotide. And different recombinant plasmids pEGFP-C3-SNCA were identified with PCR, restriction enzyme digestion and DNA sequencing. PC12 cells were transfected with different recombinant plasmids pEGFP-C3-SNCA by liposome transfection method, screened with G418, and subcloned by limited dilution method to obtain different monoclonal PC12 cell lines stably over-expressing human wild-type, A30P or A53T alpha-synuclein, respectively, and PC12 cells stably transfected with pEGFP-C3 were used as control group. These monoclonal PC12 cell lines were identified with RT-PCR, Western blot and fluorescence microscopy.RESULTS:According to result of PCR, the double digestion and gene sequencing, it was comfirmed that recombinant eukaryotic expression vectors containing wild type SNCA synonymous mutation or its Ala30Pro and Ala53Thr pathogenic mutation had been constructed successfully. By means of RT-PCR, Western blot and fluorescence microscope, it was comfirmed that objective gene sequences in PC12 cells were stably over-expressed.CONCLUSION:The recombinant pEGFP-C3-SNCA vectors containing wild type SNCA synonymous mutation or its Ala30Pro and Ala53Thr pathogenic mutations had been constructed successfully. The transfected monoclonal PC12 cells are obtained in which three SNCA gene isoforms had stable expression.

Construction of Eukaryotic Expression System of Wild Type and G88C Mutant Human Α-Synuclein

Construction of an Expression System of G209A Mutant Human Α-Synuclein

[The Wild-Type Alpha-Synuclein Over-Expression to Induce the Protein Aberrant Aggregation of Alpha-Synuclein in HEK293 Cells in Vitro].

Construction of Expression System of Wild and C279G Mutant UCHL1

[Construction of Eukaryotic Expression Vector Containing Hsnca Gene and Its Pathogenic Mutants and Its Expression in PC12 Cells].

Establishment of Α-Synuclein Transgenic Mouse Model of Parkinson's Disease

The wild-type α-synuclein over-expression to induce the protein aberrant aggregation of α-synuclein in HEK293 cells in vitro

Construction of Eukaryotic Expression Vector Containing Human Wild-Type Parkin Gene and Its Expression in PC12 Cells

Construction of Retroviral Vector pEGZ/MCS HA Containing Human SNCA Gene and Its Pathogenic Mutation

Construction of Α-Synuclein Nuclear Localization and Nuclear Export Gene Recombinant Lentivirus Vector

Influence of Different Promoters on the Expression Pattern of Mutated Human α-Synuclein in Transgenic Mice

Construction of the Eukaryotic Expression Vector Encoding IT15 Gene Fragment and Its Expression in SH-SY5Y Cells

Construction of human Alzheimer's disease' APP-expressing Plasmid

Establishment of Tetracycline-controlled A30P Mutation α-synuclein Transgenic Mice

Neuropathology in Mice Expressing Human Alpha-Synuclein.

Cloning,Expression and Purification of Human Synuclein Gamma

Transgenic Mice Expressing Human Α-Synuclein 1-103 Fragment As a Novel Model of Parkinson's Disease.

Cloning and Eukaryotic Expression Vectors Construction of Wild Type and Truncated Mouse Ciliary Neurotrophic Factor Gene

Study on the toxic effects of Aβ1-42 oligomers in SHSY5Y with human A53T mutant α-synuclein over-expression.

Construction, expression, and characterization of AG11-843 and AG11-1581.

Serine 129 Phosphorylation of Α-Synuclein Cross-Links with Tissue Transglutaminase to Form Lewy Body-Like Inclusion Bodies.